James R. Kasinger Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

James R. Kasinger is General Counsel and Secretary of CRISPR Therapeutics AG. Currently has a direct ownership of 62,597 shares of CRSP, which is worth approximately $2.51 Million. The most recent transaction as insider was on Mar 10, 2021, when has been sold 2,833 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.6K
2.33% 3M change
14.14% 12M change
Total Value Held $2.51 Million

JAMES R. KASINGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2021
BUY
Exercise of conversion of derivative security
-
2,833 Added 10.08%
25,264 Common Shares
Jan 19 2021
SELL
Open market or private sale
$5,649,875 $205.45 p/Share
27,500 Reduced 55.08%
22,431 Common Shares
Jan 19 2021
BUY
Exercise of conversion of derivative security
$1,415,975 $51.49 p/Share
27,500 Added 35.52%
49,931 Common Shares
Dec 09 2020
BUY
Exercise of conversion of derivative security
$299,994 $13.62 p/Share
22,026 Added 49.56%
22,415 Common Shares
JRK

James R. Kasinger

General Counsel and Secretary
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP